ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

Rajasthan Public Service Commission has declared the final results for the RAS 2025 examination, confirming 2,219 selections for administrative and subordinate posts. The competitive exam, comprising ...

RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

The top job in Pakistani higher education is, by design, a temporary one. The chairperson of the Higher Education Commission (HEC) now gets a mere two years — instead of four — to steward the ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Newark Mayor Ras Baraka appeared in federal court for a status conference Thursday following his arrest outside an Immigration and Customs Enforcement facility last week. Prosecutors confirmed they ...

Baraka was charged with trespassing, according to court documents. Ras Baraka, the Democratic mayor of Newark, New Jersey, was arrested on Friday while joining members of Congress at an Immigration ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...